None listed
Conditions
Brief summary
he aim of this project is to investigate patient and design-specific parameters on the efficacy of phase-step optics contact lenses and phase plates, as a solution for presbyopia. Presbyopia is an age related condition, usually initially affecting people over the age of 45, impacting the ability of the eye to focus sharply at near distances. The knowledge obtained will allow the construction of a matrix of predictors of performance to guide and optimise lens design and visual performance. Our primary hypothesis is that clinical testing will allow for measurements of varied phase-step contact lenses and phase plate designs in eyes of varied parameters. This will allow for correlations and validation with the theoretical data obtained from ray tracing analysis and in vitro physical model eye measurements.
Interventions
This trial will be a masked, randomised testing of up to 15 contact lens and/or phase plate prototypes with phase-step optics and a control lens. “Phase-step optics” is a type of surface shape that can be applied to a contact lens or phase plates to impart both far and near vision. The visual and functional assessment of participants wearing these lenses and phase plates will be compared with conventional control contact lenses. In addition, the study will investigate for associations between various baseline parameters like pupil size, corneal aberrations, ocular aberrations and visual functional performance. Participants will undergo a baseline examination in the initial visit. This visit will comprise auto-refraction, subjective refraction with visual acuity measurement and ocular assessment with a slit-lamp bio-microscope (a specialized microscope for viewing the eye). Contact lenses and/or phase plates will be trialled in each of the following two visits. The contact lenses will either be made of Polymethylmethacrylate (PMMA) or Hydroxyethylmethacrylate (HEMA or conventional hydrogel) material. Both of these materials are standard formulations of well-established contact lens materials. Their composition are defined by their chemical formulation as produced by the manufacturer of the materials. PMMA and hydrogel lenses behave differently on eye. One major difference is the presence of a ‘tear lens’. This is a microscopic volume of the wearer’s tears that resides between the back of a contact lens and the front of the cornea. In a PMMA lens, the tear lens has substantial optical power. In the hydrogel, the tear lens power is negligible. By testing both PMMA and hydrogel, we can determine the impact the tear lens optical power may have on the performance of phase-step contact lenses. The contact lenses and phase plates will have varied optical designs (surface shape). The optical design of the lenses will vary but not be limited to phase-step features such as varied groove numbers, varied spacing between grooves, varied groove heights in order to achieve different optical-visual outcomes. The maximum number of grooves on a lens shall be 24, and the maximum relative sag height (departure from the base surface geometry of the lens) shall be less than 5 microns. The criteria for this will be based on optical performance characteristics such as through-focus point-spread function and extended depth of focus range. Fitting visits will be performed by unmasked investigators and comprise contact lens fitting, assessment of contact lens visual acuity and assessment of contact lenses on eye with a slit-lamp biomicroscope. If the participant is a presbyope requiring reading spectacles of +1.50 dioptres (D) and above, no drops will be used. When this is not the case, to control the accommodation of the participant, the following will be administered: 1 drop benoxinate and 2 drops of 1% tropicamide (each of these drops separated by 5 min). This was the chosen regimen as it gives a good cycloplegic effect while being much shorter acting compared to cyclopentolate. Each of the contact lens visits will take a maximum of 2 hours in duration. All patients will trial all types of lenses in both eyes. The duration of each lens wear will be up to an hour. At the completion of each lens trial, the patient will fill out a subjective ratings of vision questionnaire utilising a 1-10 numeric rating scale. The second visit will occur at least 24 hours after the first visit. All contact lenses will be fitted and all assessments will be carried out by a registered optometrist.
Sponsors
Study design
Eligibility
Inclusion criteria
• Age 18 or greater • Able to read and comprehend English • Have vision correctable to at least 6/9 or better in at least one eye • Have ocular health findings considered to be “normal” and which would not prevent the participant from safely wearing contact lenses.
Exclusion criteria
• Existing active eye conditions • Any systemic disease that adversely affects ocular health e.g. diabetes • Recent ocular trauma or ocular surgery that is not resolved/stable or may affect vision • Prior refractive surgery (LASIK, LASEK, RK, PRK, IOL etc.) • Contraindications to contact lens wear. • Known allergy or intolerance to ingredients in any of the clinical trial products. • Use of or a need for any systemic medication or topical medications which may alter normal ocular findings • Inability to focus for prolonged periods (e.g., due to strabismus, nystagmus, etc.) • Pregnant women, breast-feeding women, or women who plan to become pregnant during the course of the study.